Medicare Enrolled
Dr. Ragheed Alturkmani, M.D.
Critical Care Medicine · Austell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alturkmani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alturkmani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alturkmani
Dr. Ragheed Alturkmani is a critical care medicine specialist in Austell, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Alturkmani performed 843 Medicare services across 659 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alturkmani received a total of $6,665 from 57 pharmaceutical and/or device companies across 283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alturkmani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 41% volume in GA
$6,665 industry payments
Medicare Practice Summary
Medicare Utilization ↗843
Medicare services
Top 41% in GA for critical care medicine
659
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
182 | $94 | $257 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $92 | $280 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
125 | $63 | $181 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
59 | $48 | $728 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
50 | $23 | $688 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $136 | $457 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
29 | $157 | $2,798 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
29 | $17 | $53 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
23 | $73 | $2,922 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
23 | $53 | $227 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $69 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $116 | $376 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
21 | $55 | $1,005 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
17 | $128 | $1,316 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
17 | $24 | $79 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $105 | $340 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
12 | $170 | $2,810 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $135 | $400 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
11 | $31 | $157 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,665
Total received (2018-2024)
Avg $952/year across 7 years
Top 24% in GA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
283
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,665 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,704
2023
$1,441
2022
$552
2021
$191
2020
$262
2019
$1,744
2018
$770
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$237
Pulmonx Corporation
$191
AstraZeneca Pharmaceuticals LP
$166
GENZYME CORPORATION
$134
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
ANI Pharmaceuticals, Inc.
$109
Amgen Inc.
$104
Regeneron Healthcare Solutions, Inc.
$75
Exelixis Inc.
$45
Karyopharm Therapeutics Inc.
$42
JAZZ PHARMACEUTICALS INC.
$39
Actelion Pharmaceuticals US, Inc.
$39
TerSera Therapeutics LLC
$39
Mallinckrodt Hospital Products Inc.
$37
Stemline Therapeutics Inc.
$30
Merck Sharp & Dohme LLC
$30
Genentech USA, Inc.
$26
HARMONY BIOSCIENCES LLC
$26
PFIZER INC.
$25
Grifols USA, LLC
$25
Mylan Specialty L.P.
$24
Daiichi Sankyo Inc.
$24
Avadel CNS Pharmaceuticals, LLC
$23
Philips North America LLC
$20
Adaptive Biotechnologies Corporation
$18
Incyte Corporation
$18
E.R. Squibb & Sons, L.L.C.
$18
Genmab U.S., Inc.
$17
Top 3 companies account for 34.8% of 2024 payments
All-time payments by company (2018-2024) ›
Pulmonx Corporation
$1,100
GlaxoSmithKline, LLC.
$943
AstraZeneca Pharmaceuticals LP
$552
Boehringer Ingelheim Pharmaceuticals, Inc.
$495
GENZYME CORPORATION
$292
Grifols USA, LLC
$272
Sunovion Pharmaceuticals Inc.
$234
Regeneron Healthcare Solutions, Inc.
$167
Galvanize Therapeutics, Inc
$149
Amgen Inc.
$146
Actelion Pharmaceuticals US, Inc.
$142
CSA Medical, Inc
$134
Mylan Specialty L.P.
$131
Merck Sharp & Dohme LLC
$126
Mallinckrodt Hospital Products Inc.
$124
Seagen Inc.
$117
Daiichi Sankyo Inc.
$111
Mallinckrodt LLC
$111
ANI Pharmaceuticals, Inc.
$109
Mallinckrodt Enterprises LLC
$102
JAZZ PHARMACEUTICALS INC.
$89
TerSera Therapeutics LLC
$68
Merck Sharp & Dohme Corporation
$61
Baxter Healthcare
$60
PFIZER INC.
$57
Insmed, Inc.
$51
Stemline Therapeutics Inc.
$49
Exelixis Inc.
$45
Karyopharm Therapeutics Inc.
$42
Janssen Biotech, Inc.
$38
MorphoSys, US Inc.
$35
La Jolla Pharmaceutical Company
$32
AbbVie Inc.
$28
Genentech USA, Inc.
$26
HARMONY BIOSCIENCES LLC
$26
Takeda Pharmaceuticals U.S.A., Inc.
$25
Avadel CNS Pharmaceuticals, LLC
$23
Electromed, Inc.
$22
United Therapeutics Corporation
$22
Circassia Pharmaceuticals Inc
$20
Philips North America LLC
$20
Bard Peripheral Vascular, Inc.
$19
Inari Medical, Inc.
$19
G1 Therapeutics, Inc.
$19
Adaptive Biotechnologies Corporation
$18
Incyte Corporation
$18
E.R. Squibb & Sons, L.L.C.
$18
Teva Pharmaceuticals USA, Inc.
$18
Allergan, Inc.
$18
Veran Medical Technologies, Inc.
$17
Intuitive Surgical, Inc.
$17
Genmab U.S., Inc.
$17
Theravance Biopharma, Inc.
$17
PORTOLA PHARMACEUTICALS, INC.
$17
Olympus America Inc.
$16
Janssen Pharmaceuticals, Inc
$13
Cook Medical LLC
$11
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · 120V · 60Hz · ACTHAR · ADCETRIS · AIRSUPRA · ALIYA SYSTEM · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Alecensa · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · CABOMETYX · CHARTIS CATHETER · CINQAIR · COOK MEDICAL HEMOSPRAY · COSELA · DALVANCE · DUPIXENT · Da Vinci Surgical System · Dymista · ELZONRIS · ENHERTU · Enhertu · Epkinly · FASENRA · FLOWTRIEVER CATHETER · GIAPREZA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IBRANCE · ICLUSIG · IMBRUVICA · JEMPERLI · KEYTRUDA · LIBTAYO · LONHALA MAGNAIR · LUMRYZ · LYNPARZA · MONJUVI · NUCALA · OFEV · OJJAARA · OPDIVO · OPSUMIT · Orserdu · PADCEV · PREVNAR - 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · S · SMARTVEST · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SYMBICORT · Spin · TAGRISSO · TEZSPIRE · TIVDAK · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TUKYSA · UPTRAVI · UTIBRON NEOHALER · Utibron · VIBATIV · WAKIX · XARELTO · XPOVIO · Xermelo · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPZELCA · ZERBAXA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
75
Per 100K population
9.8
County median income
$98,712
Nearest hospital
WELLSTAR COBB MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alturkmani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alturkmani experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Alturkmani performed 182 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alturkmani receive payments from pharmaceutical companies?
Yes. Dr. Alturkmani received a total of $6,665 from 57 companies across 283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alturkmani's costs compare to other critical care medicines in Austell?
Dr. Alturkmani's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alturkmani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Austell
Browse critical care medicines in Austell ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in GA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in GA
Which GA critical care medicines receive the most from drug and device companies.
By company
Pulmonx Corporation Payments to Doctors
See all physicians who received payments from Pulmonx Corporation.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology